Can Serum SHOX2 Methylation Predict Response to Immunotherapy in Melanoma?
Serum SHOX2 methylation may help predict response to immunotherapy in melanoma patients, a new study suggests. The results, which appear in Clinical Chemistry, may help pave the way toward more individualized treatment for melanoma patients. For the study, the researchers analyzed the blood of both patients with and without tumors for biomarkers and found that a certain […]